Physician profile
Vikrum Nanda
NPI 1093199432
$692.80
in general payments reported to CMS, 2019-2025
7 companies · $363 in 2025
The $363 reported for 2025 was more than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.01 · 2021: $25.74 · 2022: $27.75 · 2023: $112 · 2024: $103 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $578.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $578.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $380.55 | 2024-2025 | Apc Flash-Free Victory Series Low Profile, Clarity Aligners, Clarity Advanced |
| American Orthodontics Corporation | $109.29 | 2023-2024 | LP and Ifit Tubes, Radiance, Empower-Ceramic |
| 3m Company | $72.08 | 2019-2023 | Clarity Aligners |
| Align Technology, INC. | $53.77 | 2024 | Invisalign |
| Hu-Friedy Mfg. Co., LLC | $45.93 | 2019 | |
| Envista Holdings Corporation | $16.52 | 2024 | Titanium Orthos |
| Ormco Corporation | $14.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikrum Nanda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.